Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.84% |
| 2 | Technology | 15.57% |
| 3 | Consumer Discretionary | 11.88% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Alpha Pro Tech
APT
$55.4M
| $2.26M | ﹤0.01% |
561,463
-31,700
| -5% | -$129K |
|
2002
First Commonwealth Financial
FCF
$2.18B
| $2.25M | ﹤0.01% |
161,200
+35,300
| +28% | +$497K |
|
2003
California Water Service
CWT
$3.12B
| $2.25M | ﹤0.01% |
37,100
-33,300
| -47% | -$2M |
|
2004
Enerpac Tool Group
EPAC
$1.89B
| $2.25M | ﹤0.01% |
+88,300
| New | +$2.13M |
|
2005
Establishment Labs
ESTA
$2.37B
| $2.25M | ﹤0.01% |
+34,200
| New | +$2.07M |
|
|
FOCS
2006
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $2.24M | ﹤0.01% |
60,200
-38,600
| -39% | -$1.37M |
|
|
STRR
2007
Star Equity Holdings
STRR
$36.2M
| $2.24M | ﹤0.01% |
98,965
+12,146
| +14% | +$346K |
|
2008
AMC Global Media
AMCX
$510M
| $2.24M | ﹤0.01% |
142,900
+92,900
| +186% | +$1.84M |
|
|
DEN
2009
DELISTED
Denbury Inc.
DEN
| $2.24M | ﹤0.01% |
25,700
-30,500
| -54% | -$2.77M |
|
2010
Origin Bancorp
OBK
$1.68B
| $2.23M | ﹤0.01% |
60,900
+13,700
| +29% | +$544K |
|
2011
Nexa Resources
NEXA
$1.88B
| $2.23M | ﹤0.01% |
370,234
-124,190
| -25% | -$674K |
|
|
FARM
2012
DELISTED
Farmer Brothers
FARM
| $2.23M | ﹤0.01% |
483,000
-33,700
| -7% | -$174K |
|
2013
AGF US Market Neutral Anti-Beta Fund
BTAL
$298M
| $2.2M | ﹤0.01% |
+103,809
| New | +$2.15M |
|
|
HDV
2014
iShares Core High Dividend ETF
HDV
$15.1B
| $2.2M | ﹤0.01% |
+105,500
| New | +$2.16M |
|
2015
MBIA
MBI
$264M
| $2.2M | ﹤0.01% |
171,074
+89,700
| +110% | +$1.02M |
|
2016
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.3B
| $2.19M | ﹤0.01% |
44,700
+39,800
| +812% | +$1.94M |
|
|
ZH
2017
Zhihu
ZH
$273M
| $2.19M | ﹤0.01% |
281,075
+211,025
| +301% | +$1.48M |
|
2018
Simulations Plus
SLP
$371M
| $2.19M | ﹤0.01% |
59,900
+30,200
| +102% | +$1.27M |
|
2019
Schwab US Aggregate Bond ETF
SCHZ
$10.5B
| $2.17M | ﹤0.01% |
+95,000
| New | +$2.16M |
|
2020
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.8B
| $2.17M | ﹤0.01% |
+73,800
| New | +$2.16M |
|
2021
Data I/O
DAIO
$32.4M
| $2.16M | ﹤0.01% |
544,643
-10,800
| -2% | -$39K |
|
2022
Intapp
INTA
$3.09B
| $2.15M | ﹤0.01% |
86,400
+4,600
| +6% | +$102K |
|
2023
CytomX Therapeutics
CTMX
$732M
| $2.15M | ﹤0.01% |
1,340,774
-464,826
| -26% | -$688K |
|
|
BRSL
2024
Brightstar Lottery PLC
BRSL
$2.17B
| $2.14M | ﹤0.01% |
94,400
-957,400
| -91% | -$20.7M |
|
|
YALA
2025
Yalla Group
YALA
$832M
| $2.14M | ﹤0.01% |
611,000
-11,253
| -2% | -$39.6K |
|
Similar funds
Jim Simons's Q4 2022 Portfolio in Review
As of Q4 2022, Jim Simons held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Jim Simons added most to Apple in Q4 2022, an estimated $839M increase.
- Jim Simons's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Jim Simons fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Jim Simons's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Jim Simons opened 626 new positions and closed 524 in Q4 2022.
- Jim Simons's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.